✦ LIBER ✦

Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany

✍ Scribed by van Beurden-Tan, C.; Rosiñol, L.; Diels, J.; Wirth, D.; Chirita, O.; Lahuerta, J.J.; Gaugris, S.; Marsh, S.; San Miguel, J.; Spencer, M.; Treur, M.; Bladé, J.

Book ID: 122279182
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 81 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.08.498

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thalidomide-Dexamethasone as Induction T

Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency

✍ Patrizia Tosi; Elena Zamagni; Paola Tacchetti; Michela Ceccolini; Giulia Perrone 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Assessment of molecular remission rate a

Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients

✍ Silvennoinen, Raija; Kairisto, Veli; Pelliniemi, Tarja-Terttu; Putkonen, Mervi; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

A staged approach with vincristine, adri

A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma

✍ C. S. Chim; A. K. W. Lie; E. Y. T. Chan; Y. Y. Leung; S. C. W. Cheung; S. Y. T. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 319 KB

Bortezomib with thalidomide plus dexamet

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

✍ Michele Cavo; Paola Tacchetti; Francesca Patriarca; Maria Teresa Petrucci; Lucia 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 276 KB

Combination of bortezomib, thalidomide,

Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients

✍ Takashima, Shuichiro; Miyamoto, Toshihiro; Kadowaki, Masanori; Ito, Yoshikiyo; A 📂 Article 📅 2014 🏛 Carden Jennings Publishing 🌐 English ⚖ 185 KB

Sequential vincristine, adriamycin, dexa

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial

✍ Hye Jin Kim; Sung-Soo Yoon; Dong Soon Lee; Sang Kyun Sohn; Hyeon Seok Eom; Jung 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 184 KB